Expanding Patient Data Accessibility through Strategic Partnerships
BC Platforms has successfully formed a significant partnership with OmicsBank, focusing on better access to extensive patient data. This collaboration aims to enhance analytics and artificial intelligence (AI) modeling specifically for under-represented populations. With this partnership, BC Platforms can now include data from over 187 million patients worldwide, with a focused lens on populations in India and the UAE.
Unlocking the Power of Real-World Data
OmicsBank specializes in providing AI-ready data infrastructure that includes large-scale, longitudinal, and multi-omics datasets from emerging markets. The realization of this partnership allows BC Platforms to broaden its patient data reach, significantly enriching its database with more than 12 million patient lives from India and around 500,000 from the UAE. This initiative is crucial as it opens doors for further expansion into neighboring regions like Saudi Arabia, Taiwan, the Philippines, and Malaysia alongside OmicsBank’s growing network of medical partnerships.
The Value of Large-scale Databases
The integration of OmicsBank's datasets, which encompass millions of electronic medical records, pathology slides, and extensive sequencing data, presents a landmark opportunity. These datasets can be utilized modularly for specific research projects or as detailed longitudinal cohorts to facilitate advanced analytics. When paired with BC Platforms' agentic-AI data mastering technologies, the benefits manifest through better patient outcomes, improved therapeutic strategies, and effective benchmarking of multimodal AI models.
Understanding Diverse Populations in Drug Development
Both organizations recognize the importance of India's demographic and disease diversity in global health initiatives. As India constitutes approximately 20% of the global population, its role in clinical research is pivotal. However, it currently accounts for merely 2% of participants in genome-wide association studies, emphasizing the need for greater representation.
Addressing Gaps in Healthcare Research
Despite India generating a significant amount of data from domestic initiatives and international collaborations, it is still under-utilized in large-scale analytics and AI health applications. This partnership directly addresses the gap in accessible, high-quality datasets, facilitating more representative cohort selection and comprehensive research activities throughout the drug lifecycle. BC Platforms’ collaboration with OmicsBank empowers healthcare providers and researchers by enhancing the overall quality of available data.
Strengthening BC Platforms’ Global Reach
The collaboration effectively enhances BC Platforms’ existing data partnership network, expanding its reach to over 187 million patient records across 35 countries. This staggering achievement not only boosts the organization’s footprint in global patient data but also enhances therapeutic coverage across various domains like oncology, cardiovascular diseases, neurology, and rare diseases, thereby accelerating meaningful drug discovery and evidence generation.
About BC Platforms and OmicsBank
BC Platforms is committed to revolutionizing medical innovation via advanced analytics and comprehensive healthcare data. With a potent combination of harmonized multi-modal datasets and cutting-edge AI technologies, BC Platforms enables rapid insights crucial for precise medical interventions. Leading life sciences companies depend on BC Platforms for secure, thorough access to vital clinical and genomic data.
Conversely, OmicsBank prides itself on its AI-ready, multi-modal data infrastructure. By bridging emerging markets with large-scale datasets, OmicsBank facilitates effective access to relevant clinical research data. With operations prominently established in India and the Middle East, OmicsBank is poised to become a significant player in global health research.
Frequently Asked Questions
What is the significance of the partnership between BC Platforms and OmicsBank?
The partnership aims to improve access to a wide range of patient data, thus enhancing research capabilities and AI modeling for under-represented populations.
How will this partnership impact healthcare research?
It will provide essential data to better represent diverse populations in healthcare studies, ultimately leading to improved patient outcomes and healthcare strategies.
What types of data are included in OmicsBank's datasets?
The datasets include electronic medical records, pathology data, medical images, and connected biospecimens designed for research purposes.
How does this affect BC Platforms' global data network?
BC Platforms' global data network now encompasses over 187 million patients, significantly expanding their capabilities in clinical research and analytics.
Why is India considered a critical market for drug development?
As a large and diverse country, India's population offers critical insights and data necessary for developing safe and effective treatments tailored to various populations.
